Fulgent Genetics (FLGT) Other Non-Current Assets (2015 - 2026)

Fulgent Genetics has reported Other Non-Current Assets for 12 years, with the latest figure at $23.9 million in Q2 2026.

• Quarterly Other Non-Current Assets rose 2.78% year-over-year to $23.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.9 million (up 2.78% YoY) and the FY2025 annual result came in at $22.9 million, down 31.69% from the prior year.
• Other Non-Current Assets fell to $23.9 million in Q2 2026 per FLGT's latest filing, from $25.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $61.8 million in Q2 2022 and troughed at $22.9 million in Q4 2025.
• A 5-year average of $36.5 million and a median of $34.1 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets jumped 594.36% in 2022, then plunged 40.5% in 2025.
• Over 5 years, Other Non-Current Assets stood at $44.1 million in 2022, then declined by 20.9% to $34.9 million in 2023, then retreated by 4.13% to $33.5 million in 2024, then tumbled by 31.69% to $22.9 million in 2025, then increased by 4.78% to $23.9 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $23.9 million, $25.0 million, and $22.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.